Michele B. Kaufman, PharmD, BCGP, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.
You Might Also Like
- FDA Update: Romosozumab’s Uncertain Future; Plus Tocilizumab Approved for GCA
- The ACR Addresses the FDA about the Safe Adoption of Biosimilars in the U.S.; Plus Tofacitinib Approved for RA & Romosozumab May Reduce Fracture Risk
- Rheumatology Drug Updates: Uncertain Future for Romosozumab, Plus FDA Approves Tocilizumab for GCA
Also By This Author
ad goes here:advert-1
SCROLL TO CONTINUE
- Amgen. News release: Amgen and UCB receive positive vote from FDA advisory committee in favor of approval for Evenity (romosozumab). 2019 Jan 16.